Add Yahoo as a preferred source to see more of our stories on Google. The new risk score could help better manage the follow-up care for patients who've had pancreatic tumors surgically removed, and ...
Exact Sciences' Oncotype DX Breast Recurrence Score test has now been used by more than 2,000,000 patients worldwide. The test is widely used to guide individualized breast cancer treatment and help ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced a ...
A risk score based on four factors — male sex, tumor size, World Health Organization (WHO) grade, and lymphovascular invasion — predicts recurrence in patients with node-negative pancreatic ...
New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in ...
A new risk score can help predict whether a pancreatic cancer survivor will suffer a recurrence of cancer The 13-point risk score can help doctors more closely monitor patients at higher risk About 10 ...
The 13-point risk score can help doctors more closely monitor patients at higher risk About 10% of patients suffer a cancer recurrence, most often in their liver FRIDAY, Dec. 19, 2025 (HealthDay News) ...
The 13-point risk score can help doctors more closely monitor patients at higher risk About 10% of patients suffer a cancer recurrence, most often in their liver ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results